Management of Elevated INR in Elderly Patients on Warfarin

Immediate Management

For an elderly patient with elevated INR on warfarin without signs of bleeding, the American College of Cardiology recommends withholding the next 1-2 doses of warfarin and administering oral vitamin K 1-2.5 mg, then rechecking INR within 24-48 hours 1.
Withhold warfarin completely until INR returns to therapeutic range, and for INR between 5.0-9.0 without bleeding, the next 1-2 doses should be omitted, as suggested by the American College of Cardiology 2, 1.
Administer oral vitamin K 1-2.5 mg because this patient has increased bleeding risk factors, specifically advanced age, as recommended by the American Geriatrics Society 3, 1.

Elderly patients (>65-75 years) have exponentially higher bleeding risk at any given INR level, according to the European Heart Journal and the American College of Cardiology 4, 2, 1.
Recheck INR within 24-48 hours after intervention to confirm appropriate reduction, and continue monitoring every 24-48 hours until INR stabilizes in therapeutic range, as recommended by the American College of Cardiology 1.

When restarting warfarin, reduce the weekly dose by 10-20% from the previous regimen, as suggested by the American College of Cardiology 1.
The elderly require lower maintenance doses—typically less than 5 mg daily—due to increased pharmacodynamic response, according to the American Geriatrics Society and the American College of Cardiology 3, 2.

More frequent monitoring is required in elderly patients because they experience more INR fluctuations, particularly during illness or medication changes, as recommended by the American Geriatrics Society 3.
Avoid combination with antiplatelet agents, NSAIDs, SSRIs, or SNRIs during this period, as these significantly increase bleeding risk in elderly patients on warfarin, according to the European Heart Journal and the American College of Cardiology 4, 2.